|
Fusion gene ID: 43792 |
FusionGeneSummary for ZNF93_CYP4F22 |
Fusion gene summary |
Fusion gene information | Fusion gene name: ZNF93_CYP4F22 | Fusion gene ID: 43792 | Hgene | Tgene | Gene symbol | ZNF93 | CYP4F22 | Gene ID | 81931 | 126410 |
Gene name | zinc finger protein 93 | cytochrome P450 family 4 subfamily F member 22 | |
Synonyms | HPF34|HTF34|TF34|ZNF505 | ARCI5|INLNE|LI3 | |
Cytomap | 19p12 | 19p13.12 | |
Type of gene | protein-coding | protein-coding | |
Description | zinc finger protein 93zinc finger protein 505zinc finger protein HTF34 | cytochrome P450 4F22cytochrome P450, family 2, subfamily E, polypeptide 2 homologcytochrome P450, family 4, subfamily F, polypeptide 22 | |
Modification date | 20180522 | 20180329 | |
UniProtAcc | P35789 | Q6NT55 | |
Ensembl transtripts involved in fusion gene | ENST00000592613, ENST00000591366, ENST00000592160, ENST00000343769, | ENST00000269703, ENST00000601005, | |
Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 5 X 3 X 3=45 |
# samples | 2 | 5 | |
** MAII score | log2(2/8*10)=1.32192809488736 | log2(5/45*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: ZNF93 [Title/Abstract] AND CYP4F22 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ZNF93 | GO:0045892 | negative regulation of transcription, DNA-templated | 25274305 |
Hgene | ZNF93 | GO:0070895 | negative regulation of transposon integration | 25274305 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | OV | TCGA-24-1474-01A | ZNF93 | chr19 | 20011900 | + | CYP4F22 | chr19 | 15634504 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-5UTR | ENST00000592613 | ENST00000269703 | ZNF93 | chr19 | 20011900 | + | CYP4F22 | chr19 | 15634504 | + |
3UTR-intron | ENST00000592613 | ENST00000601005 | ZNF93 | chr19 | 20011900 | + | CYP4F22 | chr19 | 15634504 | + |
5CDS-5UTR | ENST00000591366 | ENST00000269703 | ZNF93 | chr19 | 20011900 | + | CYP4F22 | chr19 | 15634504 | + |
5CDS-intron | ENST00000591366 | ENST00000601005 | ZNF93 | chr19 | 20011900 | + | CYP4F22 | chr19 | 15634504 | + |
5CDS-5UTR | ENST00000592160 | ENST00000269703 | ZNF93 | chr19 | 20011900 | + | CYP4F22 | chr19 | 15634504 | + |
5CDS-intron | ENST00000592160 | ENST00000601005 | ZNF93 | chr19 | 20011900 | + | CYP4F22 | chr19 | 15634504 | + |
5CDS-5UTR | ENST00000343769 | ENST00000269703 | ZNF93 | chr19 | 20011900 | + | CYP4F22 | chr19 | 15634504 | + |
5CDS-intron | ENST00000343769 | ENST00000601005 | ZNF93 | chr19 | 20011900 | + | CYP4F22 | chr19 | 15634504 | + |
Top |
FusionProtFeatures for ZNF93_CYP4F22 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ZNF93 | CYP4F22 |
Transcription factor specifically required to represslong interspersed nuclear element 1 (L1) retrotransposons:recognizes and binds L1 sequences and repress their expression byrecruiting a repressive complex containing TRIM28/KAP1(PubMed:25274305). Not able to repress expression of all subtypesof L1 elements. Binds to the 5' end of L1PA4, L1PA5 and L1PA6subtypes, and some L1PA3 subtypes. Does not bind to L1PA7 or oldersubtypes nor at the most recently evolved L1PA2 and L1Hs. 50% ofL1PA3 elements have lost the ZNF93-binding site, explaining whyZNF93 is not able to repress their expression (PubMed:25274305).{ECO:0000269|PubMed:25274305}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ZNF93_CYP4F22 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ZNF93_CYP4F22 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
ZNF93 | FBL | CYP4F22 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ZNF93_CYP4F22 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ZNF93_CYP4F22 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | CYP4F22 | C1858133 | Ichthyosis, Nonlamellar and Nonerythrodermic, Congenital, Autosomal Recessive | 1 | UNIPROT |